Linda Rorick‐Kehn

Melanin-Concentrating Hormone-1 Receptor Modulates Neuroendocrine, Behavioral, and Corticolimbic Neurochemical Stress Responses in Mice

Daniel G. Smith, Richard J. Davis, Linda Rorick‐Kehn et al. · Neuropsychopharmacology · 2005 · 114 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Duration of Action of a Broad Range of Selective κ-Opioid Receptor Antagonists Is Positively Correlated with c-Jun N-Terminal Kinase-1 Activation

Erica J. Melief, Mayumi Miyatake, F. Ivy Carroll et al. · Molecular Pharmacology · 2011 · 105 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes

Matthew Fell, Jeffrey M. Witkin, Julie F. Falcone et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 99 citations

Medicine, Neuroscience, Pharmacology +17

Safety, tolerability, and pharmacokinetic evaluation of single‐ and multiple‐ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects

Stephen L. Lowe, Conrad J. Wong, Jennifer Witcher et al. · The Journal of Clinical Pharmacology · 2014 · 91 citations

Medicine, Pharmacokinetics, Pharmacology +14

A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating Disorder

M.A. Statnick, Y. Chen, Jeffrey M. Witkin et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 51 citations

Medicine, Neuroscience, Pharmacology +15